ArticleMedicine2025
Investigating the causal relationships between attention-deficit/hyperactivity disorder and autoimmune diseases: Evidence from Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) and autoimmune diseases have been found to be correlated in the observational studies, but the causal relationships have not been fully investigated. Two-sample Mendelian randomization (MR) analysis was used to explore the causal relationships between ADHD and 8 autoimmune disorders (systemic lupus erythematosus, Crohn disease, ulcerative colitis, type 1 diabetes, rheumatoid arthritis, psoriasis, ankylosing spondylitis [AS], and multiple sclerosis) with the publicly available genome-wide association study data in the European populations. Inverse-variance weighted (IVW), weighted median, and MR-Egger were used to estimate the causal effects. Extensive sensitivity analyses were employed to validate the 3 assumptions of MR and robustness of the results. Multivariable MR (MVMR) analysis was used to evaluate the direct causal effects adjusting for the potential confounding factors. The potential mediators of the causal effects were explored through the 2-step MR mediation analysis. With the Bonferroni corrected threshold, the IVW results indicated that genetically determined higher risk of ADHD was significantly associated with increased risk of psoriasis (IVW OR: 1.29; 95% CI: 1.11-1.49, P = 6.3e-04), but not with other autoimmune disorders. The reverse MR didn't find significant causal effects of autoimmune diseases on ADHD. MVMR analysis indicated that the significant causal effects of ADHD on psoriasis remained significant after accounting for obesity, alcohol drinking, depression, and biological sex, but became nonsignificant when adjusting for smoking. Further mediation analysis suggested smoking might partially mediate the causal effects of ADHD on psoriasis (mediated percentage: 11.16%, 95% CI: 1.54% to 20.77%, P = .023). There is a significant causal relationship between ADHD and psoriasis, but not with other autoimmune disorders. The causal effects might be mediate by smoking. Our findings suggested that early prevention and lifestyle changes (such as smoking cessation) might be helpful to reduce the risk of developing psoriasis for ADHD patients. Further investigations were warranted to explore the underlying mechanisms and the potential clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.